Results 101 to 110 of about 25,328 (236)

Rapid detection of temocillin resistance in Enterobacterales

Journal of Antimicrobial Chemotherapy, 2023
Jacqueline Findlay, Laurent Poirel, Patrice Nordmann   +2 more
openaire   +2 more sources

Plasmid-Mediated Spread of Carbapenem Resistance in Enterobacterales: A Three-Year Genome-Based Survey

Antibiotics
The worldwide emergence and dissemination of carbapenem-resistant Gram-negative bacteria (CRGNB) is a challenging problem of antimicrobial resistance today.
Yancheng Yao, C. Imirzalioglu, L. Falgenhauer, Jane C. Falgenhauer, Petra Heinmüller, Eugen Domann, Trinad Chakraborty   +6 more
semanticscholar   +1 more source

Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22

Journal of Antimicrobial Chemotherapy
Objectives Taniborbactam is a boronate-based β-lactamase inhibitor in clinical development in combination with cefepime. Methods Cefepime–taniborbactam and comparator broth microdilution MICs were determined for patient isolates of Enterobacterales (n ...
J. Karlowsky, M. Wise, M. Hackel, David A. Six, Tsuyoshi Uehara, Denis M. Daigle, D. Pevear, G. Moeck, D. Sahm   +8 more
semanticscholar   +1 more source

Establishing the reference broth microdilution MIC method for cefepime-taniborbactam

Journal of Clinical Microbiology
The investigational β-lactam/β-lactamase inhibitor combination cefepime-taniborbactam is intended as therapy for serious infections caused by Gram-negative pathogens resistant to third-generation cephalosporins and carbapenems.
Adam Belley, Susan M. Cusick, Dan C. Pevear, Laura Koeth, Jeanna DiFranco-Fisher, Nimmi Kothari, Stephen Hawser, Greg Moeck   +7 more
doaj   +1 more source

An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by Enterobacterales in Critically Ill Adult Patients

Infection and Drug Resistance, 2021
Milo Gatti,1,2 Bruno Viaggi,3 Gian Maria Rossolini,4– 6 Federico Pea,1,2 Pierluigi Viale1,7 1Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; 2SSD Clinical Pharmacology, IRCCS Azienda Ospedaliero ...
Gatti M, Viaggi B, Rossolini GM, Pea F, Viale P   +4 more
doaj  

Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae.

European Journal of Clinical Microbiology and Infectious Diseases
PURPOSE Real-world experience with meropenem/vaborbactam (M/V) is limited. Our aim is to report a clinical experience of M/V in the treatment of resistant Gram-negative bacilli.
G. Tiseo, V. Galfo, N. Riccardi, L. Suardi, Manuela Pogliaghi, Cesira Giordano, A. Leonildi, Simona Barnini, M. Falcone   +8 more
semanticscholar   +1 more source

In vitro antibacterial activity of tigecycline against multidrug-resistant bacteria isolated at the Sourô Sanou University teaching hospital in Bobo-Dioulasso, Burkina Faso

African Journal of Laboratory Medicine
Background: Tigecycline, an antibiotic effective against multidrug-resistant bacteria (MDRB), remains inaccessible in Burkina Faso’s hospitals for urgent care. Given the resulting therapeutic challenges and mortality in emergency services, evidence-based
Odilon D. Kaboré, Mélissa J. Gonfouli, Merci Muhigwa, Abdourahmane Sow, Fernand Michodigni, André Nagalo, Jacques Zoungrana, Arsène Hema, Augustin Konkobo, Hervé Kafando, Adama Ouattara, Armel Poda, Sylvain Godreuil, Abdoul-Salam Ouedraogo   +13 more
doaj   +1 more source

Detection of Plasmid-Mediated Mobile Colistin Resistance Gene (mcr-1) in Enterobacterales Isolates from a University Hospital

Infection and Drug Resistance, 2021
Mera Mohammed Galal Anan,1 Eman Ahmed El-Seidi,1 Marwa Salah Mostafa,1 Laila Ahmed Rashed,2 Doaa Mahdy El-Wakil1 1Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Cairo, Egypt; 2Department of Biochemistry and ...
Anan MMG, El-Seidi EA, Mostafa MS, Rashed LA, El-Wakil DM   +4 more
doaj  

Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study

Journal of Antimicrobial Chemotherapy
Background Carbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) are a major threat to patients. To date, data on risk factors have been limited, with low internal and external validity. In this multicentre study, risk factors for CRE
Hongyu Zhou, N. Buetti, Salvador Pérez-Galera, J. Bravo-Ferrer, B. Gutiérrez-Gutiérrez, M. Paniagua-García, J. Feifel, J. Sauser, T. Kostyanev, R. Cantón, Lionel K Tan, D. Basoulis, V. Pintado, Emmanuel Roilides, G. Dragovac, J. Torre-Cisneros, D. Medic, M. Akova, Herman Goossens, M. Bonten, S. Harbarth, Jesús Rodríguez-Baño, M. D. de Kraker   +22 more
semanticscholar   +1 more source

Faecal carriage of multidrug-resistant Enterobacterales in hospitalisaed and outpatient children in northern India: A cross-sectional study

African Journal of Laboratory Medicine
Background: Asymptomatic intestinal carriage of multidrug-resistant (MDR) Enterobacterales in children is increasingly recognised as an important reservoir for transmission and subsequent infection.
Akansha Goyal, Jannatbir Kaur, Sapna Chauhan   +2 more
doaj   +1 more source